Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension

  • Authors:
    • Yuejiang Jiao
    • Hongwei Jiang
    • Haibo Lu
    • Yiping Yang
    • Yanfang Zhang
    • Kun Zhang
    • Hui Liu
  • View Affiliations / Copyright

    Affiliations: Department of Endocrinology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan 471009, P.R. China, Department of Endocrinology, The 1st Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471033, P.R. China
  • Pages: 3658-3662
    |
    Published online on: August 20, 2018
       https://doi.org/10.3892/etm.2018.6621
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study was designed to investigate the effect of hypoxia inducible factor‑1α (HIF‑1α) on diabetic nephropathy (DN) with hypertension. HIF‑1α deficient mice (Mx/HIF‑1α‑/‑) were constructed and treated with streptozotocin (STZ) injection for hypertensive DN induction. Normal C57BL/6 mice received STZ or no treatment (normal) were considered as controls. Three days post STZ administration; body weight, fasting blood glucose (FBG), 24 h urinary albumin and systolic blood pressure (SBP) were measured weekly. Periodic acid‑Schiff's staining was performed for histologic analysis of glomeruli damage. In comparison with the normal control, significant upregulation and downregulation of HIF‑1α was, respectively, detected in diabetic and HIF‑1α‑/‑ mice (P<0.01). In comparison with STZ‑induced diabetic mice, HIF‑1α‑/‑ + STZ mice displayed reduced body weight, and increased FBG, urinary albumin and SBP. PAS showed HIF‑1α‑/‑ + STZ mice had damaged kidney tissues, with more renal fibrosis and apparent glomerular hypertrophy. These results demonstrated that HIF‑1α deficiency accelerated DN progression with increasing hypertension in mice.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Xie S, Lu K, Zhang Y, Song X, Tan M and Wang C: Effects of Jiangya Xiaoke prescription on TGF-β1 in diabetic nephropathy rats with hypertension and its mechanisms. Int J Clin Exp Med. 8:5129–5136. 2015.PubMed/NCBI

2 

Grossman E: Should we treat prehypertension in diabetes? What are the cons? Diabetes Care. 32 Suppl 2:S280–S283. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Nordquist L, Friederich-Persson M, Fasching A, Liss P, Shoji K, Nangaku M, Hansell P and Palm F: Activation of hypoxia-inducible factors prevents diabetic nephropathy. J Am Soc Nephrol. 26:328–338. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Gu HF, Zheng X, Abu Seman N, Gu T, Botusan IR, Sunkari VG, Lokman EF, Brismar K and Catrina SB: Impact of the hypoxia-inducible factor-1 α (HIF1A) Pro582Ser polymorphism on diabetes nephropathy. Diabetes Care. 36:415–421. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Luo R, Zhang W, Zhao C, Zhang Y, Grenz A, Eltzschig HK, Tou L, Kellems RW and Xia Y: Rt-pcr profiling reveals the essential role of endothelial hif-1a in Hypertensive Nephropathy. Hypertension. 62:A312013.

6 

Yan H and Su Gf: Expression and significance of HIF-1 α and VEGF in rats with diabetic retinopathy. Asian Pac J Trop Med. 7:237–240. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, Kubo A, Akai Y, Rankin EB, Neilson EG, et al: Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol. 295:F1023–F1029. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol. 17:17–25. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL, Jones RC, Picard MH and Zapol WM: Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest. 101:2468–2477. 1998. View Article : Google Scholar : PubMed/NCBI

10 

Mazzali M, Jefferson JA, Ni Z, Vaziri ND and Johnson RJ: Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int. 63:2088–2093. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Fu W, Wang Y, Jin Z, Wang H, Cheng W, Zhou H, Yin P and Peng W: Losartan alleviates renal fibrosis by down-regulating HIF-1α and up-regulating MMP-9/TIMP-1 in rats with 5/6 nephrectomy. Ren Fail. 34:1297–1304. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Yamaji-Kegan K, Takimoto E, Semenza GL and Johns RA: Hypoxia-inducible factor 1α is a critical downstream mediator for hypoxia-induced mitogenic factor (FIZZ1/RELMα)-mediated pulmonary hypertension, in A51. Experimental models of pulmonary hypertension. Am J Respir Crit Care Med. 191:A19242015.

13 

Hu J, Zhu Q, Li PL, Boini KM and Li N: Inhibition of hypoxia inducible factor-1α in the renal medulla contributes to fructose-induced salt-sensitive hypertension. FASEB J. 30 1 Suppl:1216.22016.

14 

Veith C, Zakrzewicz D, Dahal BK, Bálint Z, Murmann K, Wygrecka M, Seeger W, Schermuly RT, Weissmann N and Kwapiszewska G: Hypoxia-or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment. Thromb Haemost. 112:1288–1303. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Biju MP, Akai Y, Shrimanker N and Haase VH: Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent. Am J Physiol Renal Physiol. 289:F1217–F1226. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thébaud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry MS, et al: An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: Uimilarities to human pulmonary arterial hypertension. Circulation. 113:2630–2641. 2006. View Article : Google Scholar : PubMed/NCBI

17 

Shimoda LA, Manalo DJ, Sham JS, Semenza GL and Sylvester JT: Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol. 281:L202–L208. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Basu RK, Hubchak S, Hayashida T, Runyan CE, Schumacker PT and Schnaper HW: Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am J Physiol Renal Physiol. 300:F898–F905. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Du G, Leone M, Romeijn S, Kersten G, Jiskoot W and Bouwstra JA: Immunogenicity of diphtheria toxoid and poly(I:C) loaded cationic liposomes after hollow microneedle-mediated intradermal injection in mice. Int J Pharm. 547:250–257. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Zhu H, Li X, Yuan M, Wan W, Hu M, Wang X and Jiang X: Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium. Exp Ther Med. 14:3609–3615. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Lim AK, Ma FY, Nikolic-Paterson DJ, Ozols E, Young MJ, Bennett BL, Friedman GC and Tesch GH: Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats. Am J Nephrol. 34:337–346. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Jara A, Benner CM, Sim D, Liu X, List EO, Householder LA, Berryman DE and Kopchick JJ: Elevated systolic blood pressure in male GH transgenic mice is age dependent. Endocrinology. 155:975–986. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Franzén S: The role of hypoxia for the development of diabetic nephropathy: Temporal relationship and involvement of endothelin receptor signaling. Linköping Univ Electron Press; pp. 532016

24 

Bohuslavova R, Kolar F, Sedmera D, Skvorova L, Papousek F, Neckar J and Pavlinkova G: Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice. BMC Endocr Disord. 14:112014. View Article : Google Scholar : PubMed/NCBI

25 

Mori KP, Yokoi H, Kasahara M, Imamaki H, Ishii A, Kuwabara T, Koga K, Kato Y, Toda N, Ohno S, et al: Increase of total nephron albumin filtration and reabsorption in diabetic nephropathy. J Am Soc Nephrol. 28:278–289. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Teumer A, Tin A, Sorice R, Gorski M, Yeo NC, Chu AY, Li M, Li Y, Mijatovic V, Ko YA, et al: Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. Diabetes. 65:803–817. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Catrina SB, Okamoto K, Pereira T, Brismar K and Poellinger L: Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes. 53:3226–3232. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Gao W, Ferguson G, Connell P, Walshe T, Murphy R, Birney YA, O'Brien C and Cahill PA: High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. J Mol Cell Cardiol. 42:609–619. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Fu W, Wang Y, Jin Z, Wang H, Cheng W, Zhou H, Yin P and Peng W: Losartan alleviates renal fibrosis by down-regulating HIF-1α and up-regulating MMP-9/TIMP-1 in rats with 5/6 nephrectomy. Ren Fail. 34:1297–1304. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jiao Y, Jiang H, Lu H, Yang Y, Zhang Y, Zhang K and Liu H: Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension. Exp Ther Med 16: 3658-3662, 2018.
APA
Jiao, Y., Jiang, H., Lu, H., Yang, Y., Zhang, Y., Zhang, K., & Liu, H. (2018). Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension. Experimental and Therapeutic Medicine, 16, 3658-3662. https://doi.org/10.3892/etm.2018.6621
MLA
Jiao, Y., Jiang, H., Lu, H., Yang, Y., Zhang, Y., Zhang, K., Liu, H."Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension". Experimental and Therapeutic Medicine 16.4 (2018): 3658-3662.
Chicago
Jiao, Y., Jiang, H., Lu, H., Yang, Y., Zhang, Y., Zhang, K., Liu, H."Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3658-3662. https://doi.org/10.3892/etm.2018.6621
Copy and paste a formatted citation
x
Spandidos Publications style
Jiao Y, Jiang H, Lu H, Yang Y, Zhang Y, Zhang K and Liu H: Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension. Exp Ther Med 16: 3658-3662, 2018.
APA
Jiao, Y., Jiang, H., Lu, H., Yang, Y., Zhang, Y., Zhang, K., & Liu, H. (2018). Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension. Experimental and Therapeutic Medicine, 16, 3658-3662. https://doi.org/10.3892/etm.2018.6621
MLA
Jiao, Y., Jiang, H., Lu, H., Yang, Y., Zhang, Y., Zhang, K., Liu, H."Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension". Experimental and Therapeutic Medicine 16.4 (2018): 3658-3662.
Chicago
Jiao, Y., Jiang, H., Lu, H., Yang, Y., Zhang, Y., Zhang, K., Liu, H."Deficiency of hypoxia inducible factor‑1α promoted progression of diabetic nephropathy with hypertension". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3658-3662. https://doi.org/10.3892/etm.2018.6621
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team